ViaCyte funding for functional Type 1 cure 16/07/2021 No Comments ViaCyte has closed a $45m Series D financing tranche in the United States, bringing the total round to more than $115m, reports DrugDeliveryBusiness.com. The funding will Read More »
Stem Cell ‘cure’ for Type 1 diabetes 22/11/2017 No Comments As reported by Andy Coghlan in New Scientist “In early August 2017, two people with Type 1 diabetes became the first to receive implants containing Read More »